Can an ezetimibe tablet (e.g., Ezetrol) be crushed for administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Can Ezetimibe Tablets Be Crushed?

No, ezetimibe tablets should not be crushed. The combination product of bempedoic acid and ezetimibe specifically states "Swallow whole" in the dosing instructions 1.

Key Administration Guidance

The available evidence indicates that ezetimibe formulations are designed for intact oral administration:

  • Standard ezetimibe tablets (10 mg): Should be taken orally once daily, with or without food 1
  • Combination bempedoic acid/ezetimibe tablets: Must be swallowed whole according to prescribing information 1

Clinical Reasoning

The requirement to swallow the combination tablet whole suggests pharmaceutical considerations that likely apply to ezetimibe formulations generally:

  • Pharmacokinetic profile: Ezetimibe undergoes rapid absorption and extensive first-pass metabolism (>80%) to its active glucuronide metabolite 2. The tablet formulation is designed to optimize this absorption pattern.

  • Enterohepatic recirculation: Ezetimibe exhibits significant enterohepatic recycling with a terminal half-life of approximately 22 hours 2, 3. Crushing the tablet could potentially disrupt the intended release characteristics and affect this recirculation pattern.

  • Bioavailability considerations: The drug's absorption is not affected by food, but the intact tablet formulation appears designed to maintain consistent bioavailability 2.

Practical Alternatives

For patients with swallowing difficulties who cannot take intact tablets, consult with a pharmacist or the prescribing physician about:

  • Alternative lipid-lowering strategies
  • Injectable options (such as PCSK9 inhibitors) if appropriate for the patient's cardiovascular risk profile
  • Compounded formulations if available and appropriate

The explicit "swallow whole" instruction for the combination product provides the clearest guidance that ezetimibe tablets should not be altered before administration.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.